Clinical Trials Browser

Phase 2 × Uterine Neoplasms × pembrolizumab × Clear all

NCT06180733 2023-12-22

PAM-II

Phase 2 Recruiting

GynecologicLymphoid

Lymphoma, Follicular, Uterine Neoplasms, Endometrial Neoplasms

NCT03192059 2021-09-08

PRIMMO

Phase 2 Completed

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms